A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Clinical trial NCT05061147 · UNKNOWN
Trial details
- NCT number
- NCT05061147
- Sponsor
- Maxinovel Pty., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2022-04-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.